GPR91 represents a central molecular switch in RA and correspondingly inhibition or deletion of GPR91 ameliorated the disease (Littlewood-Evans et al., 2016; Saraiva et al., 2018; Velcicky et al., 2020). This evidence concerns the gene SUCNR1 and rheumatoid arthritis.